BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 3009493)

  • 1. Cellular basis for the species differences in sensitivity to cardiac glycosides (digitalis).
    Gupta RS; Chopra A; Stetsko DK
    J Cell Physiol; 1986 May; 127(2):197-206. PubMed ID: 3009493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-resistance and biochemical studies with two classes of HeLa cell mutants resistant to cardiac glycosides. The unusual behavior of cardenolide SC4453.
    Gupta RS; Chopra A
    J Biol Chem; 1985 Jun; 260(11):6843-50. PubMed ID: 2987235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and cross-resistance studies with HeLa cell mutants resistant to cardiac glycoside SC4453. Regulation of the resistant form of Na+/K+-ATPase in the mutant cells.
    Chopra A; Gupta RS
    J Biol Chem; 1986 Feb; 261(5):2034-40. PubMed ID: 3003091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cell mutants affected in the interaction of the 12 beta-OH group of cardiac glycosides with the digitalis receptor.
    Gupta RS; Chopra A
    Biochem Pharmacol; 1987 Nov; 36(22):3829-33. PubMed ID: 2825704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the sugar moiety in the inhibitory action of the cardiac glycosides on the palytoxin-induced responses in vascular smooth muscles.
    Ozaki H; Nagase H; Urakawa N
    J Pharmacol Exp Ther; 1984 Oct; 231(1):153-8. PubMed ID: 6149301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischemia-induced enhancement of digitalis sensitivity in isolated guinea-pig heart.
    Kim DH; Akera T; Kennedy RH
    J Pharmacol Exp Ther; 1983 Aug; 226(2):335-42. PubMed ID: 6308206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of human and mouse melanoma cell sensitivities to oleandrin.
    Lin Y; Dubinsky WP; Ho DH; Felix E; Newman RA
    J Exp Ther Oncol; 2008; 7(3):195-205. PubMed ID: 19066128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Species-specific differences in the toxicity of rhodamine 123 towards cultured mammalian cells.
    Gupta RS; Dudani AK
    J Cell Physiol; 1987 Mar; 130(3):321-7. PubMed ID: 3558490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species-specific differences in toxicity of antimitotic agents toward cultured mammalian cells.
    Gupta RS
    J Natl Cancer Inst; 1985 Jan; 74(1):159-64. PubMed ID: 3855475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species-specific differences in the toxicity and mutagenicity of the anticancer drugs mithramycin, chromomycin A3, and olivomycin.
    Singh B; Gupta RS
    Cancer Res; 1985 Jun; 45(6):2813-20. PubMed ID: 3157449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on cardioactive steroids. III. Characterization of different cardiac glycosides by their effects on contractility and rhythmicity at different extracellular potassium concentrations.
    Haustein KO; Graumann G; Stephan B
    Acta Biol Med Ger; 1975; 34(6):1065-73. PubMed ID: 1199622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of peripheral blood mononuclear cell proliferation by cardiac glycosides.
    Gentile DA; Henry J; Katz AJ; Skoner DP
    Ann Allergy Asthma Immunol; 1997 May; 78(5):466-72. PubMed ID: 9164359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the affinity of human, beef and cat heart (Na+ + K+)-ATPase for different digitalis derivatives.
    Brown L; Erdmann E
    Arzneimittelforschung; 1984; 34(10):1314-8. PubMed ID: 6097261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the differences between ouabain and digitalis glycosides.
    Fuerstenwerth H
    Am J Ther; 2014; 21(1):35-42. PubMed ID: 21642827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digitalis structure-activity relationship analyses. Conclusions from indirect binding studies with cardiac (Na+ + K+)-ATPase.
    Brown L; Erdmann E; Thomas R
    Biochem Pharmacol; 1983 Sep; 32(18):2767-74. PubMed ID: 6313008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium/potassium ATPase (Na+, K+-ATPase) and ouabain/related cardiac glycosides: A new paradigm for development of anti- breast cancer drugs?
    Chen JQ; Contreras RG; Wang R; Fernandez SV; Shoshani L; Russo IH; Cereijido M; Russo J
    Breast Cancer Res Treat; 2006 Mar; 96(1):1-15. PubMed ID: 16322895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidation of the Na+, K+-ATPase digitalis binding site.
    Keenan SM; DeLisle RK; Welsh WJ; Paula S; Ball WJ
    J Mol Graph Model; 2005 Jun; 23(6):465-75. PubMed ID: 15886034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Na+, K+-ATPase of the canine mesenteric artery.
    Wallick ET; Adams RJ; Fondacaro JD; Jacobson ED
    Fed Proc; 1982 Apr; 41(6):2101-5. PubMed ID: 6281071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between cardiotonic steroids and Na,K-ATPase. Effects of pH and ouabain-induced changes in enzyme conformation.
    Cornelius F; Mahmmoud YA
    Biochemistry; 2009 Oct; 48(42):10056-65. PubMed ID: 19778013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species restriction of the mitogenicity induced by lanatoside C. Lymphocyte activation by digitalis glycosides is confined to cells from digitalis resistant species.
    Hammarström L; Smith CI
    Immunology; 1979 Jun; 37(2):389-96. PubMed ID: 157324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.